Belize vs Bolivia: Cause of death, by non-communicable diseases, ages 0-4, female
Belize
22.6%
in 2021
Bolivia
22.4%
in 2021
Belize rank
118th
Bolivia rank
119th
Cause of death, by non-communicable diseases, ages 0-4, female over time
- Belize
- Bolivia
How they compare
Belize currently reports 22.6% against 22.4% in Bolivia, a difference of 0.2%.
Across all 6 years both countries report, Belize has been ahead every year.
Belize ranks 118th and Bolivia ranks 119th of 185 countries.
Belize has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belize | Bolivia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.8% | 13.0% | 7.8% | Belize |
| 2010s | 30.6% | 19.1% | 11.5% | Belize |
| 2020s | 23.4% | 22.0% | 1.4% | Belize |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, Belize or Bolivia?
- Belize, at 22.6% against 22.4% in Bolivia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between Belize and Bolivia?
- 0.2%, with Belize ahead.
- How many years of comparable data are there for Belize and Bolivia?
- 6 years are reported by both, from 2000 to 2021.
- How do Belize and Bolivia rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- Belize ranks 118th and Bolivia ranks 119th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.